Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction

Youlan L. Gu, Adriaan A. Voors, Felix Zijlstra, Hans L. Hillege, Joachim Struck, Serge Masson, Tarcisio Vago, Stefan D. Anker, Ad F M Van Den Heuvel, Dirk J. Van Veldhuisen, Bart J G L De Smet

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Background Early detection of acute myocardial infarction (AMI) using cardiac biomarkers of myocardial necrosis remains limited since these biomarkers do not rise within the first hours from onset of AMI. We aimed to compare the temporal release pattern of the C-terminal portion of provasopressin (copeptin) with conventional cardiac biomarkers, including creatine kinase isoenzyme (CK-MB), cardiac troponin T (cTnT), and high-sensitivity cTnT (hs-cTnT), in patients with ST-elevation AMI. Methods We included 145 patients undergoing successful primary percutaneous coronary intervention (PCI) for a first ST-elevation AMI presenting within 12 h of symptom onset. Blood samples were taken on admission and at four time points within the first 24 h after PCI. Results In contrast to all other markers, copeptin levels were already elevated on admission and were higher with a shorter time from symptom onset to reperfusion and lower systolic blood pressure. Copeptin levels peaked immediately after symptom onset at a maximum of 249 pmol/L and normalized within 10 h. In contrast, CK-MB, cTnT, and hs-cTnT peaked after 14 h from symptom onset at a maximum of 275 U/L, 5.75 lg/L, and 4.16 lg/L, respectively, and decreased more gradually. Conclusions Copeptin has a distinct release pattern in patients with ST-elevation AMI, peaking within the first hour after symptom onset before conventional cardiac biomarkers and falling to normal ranges within the first day. Further studies are required to determine the exact role of copeptin in AMI suspects presenting within the first hours after symptom onset.

Original languageEnglish
Pages (from-to)1069-1076
Number of pages8
JournalClinical Research in Cardiology
Volume100
Issue number12
DOIs
Publication statusPublished - Dec 2011

Fingerprint

Biomarkers
Myocardial Infarction
Troponin T
Percutaneous Coronary Intervention
Blood Pressure
Creatine Kinase
Isoenzymes
Reperfusion
copeptins
Reference Values
Necrosis
ST Elevation Myocardial Infarction

Keywords

  • Acute myocardial infarction
  • Biomarkers
  • Copeptin
  • Temporal release pattern
  • Troponin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Gu, Y. L., Voors, A. A., Zijlstra, F., Hillege, H. L., Struck, J., Masson, S., ... De Smet, B. J. G. L. (2011). Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction. Clinical Research in Cardiology, 100(12), 1069-1076. https://doi.org/10.1007/s00392-011-0343-y

Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction. / Gu, Youlan L.; Voors, Adriaan A.; Zijlstra, Felix; Hillege, Hans L.; Struck, Joachim; Masson, Serge; Vago, Tarcisio; Anker, Stefan D.; Van Den Heuvel, Ad F M; Van Veldhuisen, Dirk J.; De Smet, Bart J G L.

In: Clinical Research in Cardiology, Vol. 100, No. 12, 12.2011, p. 1069-1076.

Research output: Contribution to journalArticle

Gu, YL, Voors, AA, Zijlstra, F, Hillege, HL, Struck, J, Masson, S, Vago, T, Anker, SD, Van Den Heuvel, AFM, Van Veldhuisen, DJ & De Smet, BJGL 2011, 'Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction', Clinical Research in Cardiology, vol. 100, no. 12, pp. 1069-1076. https://doi.org/10.1007/s00392-011-0343-y
Gu, Youlan L. ; Voors, Adriaan A. ; Zijlstra, Felix ; Hillege, Hans L. ; Struck, Joachim ; Masson, Serge ; Vago, Tarcisio ; Anker, Stefan D. ; Van Den Heuvel, Ad F M ; Van Veldhuisen, Dirk J. ; De Smet, Bart J G L. / Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction. In: Clinical Research in Cardiology. 2011 ; Vol. 100, No. 12. pp. 1069-1076.
@article{98370c935f964acea955c77afe38842a,
title = "Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction",
abstract = "Background Early detection of acute myocardial infarction (AMI) using cardiac biomarkers of myocardial necrosis remains limited since these biomarkers do not rise within the first hours from onset of AMI. We aimed to compare the temporal release pattern of the C-terminal portion of provasopressin (copeptin) with conventional cardiac biomarkers, including creatine kinase isoenzyme (CK-MB), cardiac troponin T (cTnT), and high-sensitivity cTnT (hs-cTnT), in patients with ST-elevation AMI. Methods We included 145 patients undergoing successful primary percutaneous coronary intervention (PCI) for a first ST-elevation AMI presenting within 12 h of symptom onset. Blood samples were taken on admission and at four time points within the first 24 h after PCI. Results In contrast to all other markers, copeptin levels were already elevated on admission and were higher with a shorter time from symptom onset to reperfusion and lower systolic blood pressure. Copeptin levels peaked immediately after symptom onset at a maximum of 249 pmol/L and normalized within 10 h. In contrast, CK-MB, cTnT, and hs-cTnT peaked after 14 h from symptom onset at a maximum of 275 U/L, 5.75 lg/L, and 4.16 lg/L, respectively, and decreased more gradually. Conclusions Copeptin has a distinct release pattern in patients with ST-elevation AMI, peaking within the first hour after symptom onset before conventional cardiac biomarkers and falling to normal ranges within the first day. Further studies are required to determine the exact role of copeptin in AMI suspects presenting within the first hours after symptom onset.",
keywords = "Acute myocardial infarction, Biomarkers, Copeptin, Temporal release pattern, Troponin",
author = "Gu, {Youlan L.} and Voors, {Adriaan A.} and Felix Zijlstra and Hillege, {Hans L.} and Joachim Struck and Serge Masson and Tarcisio Vago and Anker, {Stefan D.} and {Van Den Heuvel}, {Ad F M} and {Van Veldhuisen}, {Dirk J.} and {De Smet}, {Bart J G L}",
year = "2011",
month = "12",
doi = "10.1007/s00392-011-0343-y",
language = "English",
volume = "100",
pages = "1069--1076",
journal = "Clinical Research in Cardiology",
issn = "1861-0684",
publisher = "D. Steinkopff-Verlag",
number = "12",

}

TY - JOUR

T1 - Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction

AU - Gu, Youlan L.

AU - Voors, Adriaan A.

AU - Zijlstra, Felix

AU - Hillege, Hans L.

AU - Struck, Joachim

AU - Masson, Serge

AU - Vago, Tarcisio

AU - Anker, Stefan D.

AU - Van Den Heuvel, Ad F M

AU - Van Veldhuisen, Dirk J.

AU - De Smet, Bart J G L

PY - 2011/12

Y1 - 2011/12

N2 - Background Early detection of acute myocardial infarction (AMI) using cardiac biomarkers of myocardial necrosis remains limited since these biomarkers do not rise within the first hours from onset of AMI. We aimed to compare the temporal release pattern of the C-terminal portion of provasopressin (copeptin) with conventional cardiac biomarkers, including creatine kinase isoenzyme (CK-MB), cardiac troponin T (cTnT), and high-sensitivity cTnT (hs-cTnT), in patients with ST-elevation AMI. Methods We included 145 patients undergoing successful primary percutaneous coronary intervention (PCI) for a first ST-elevation AMI presenting within 12 h of symptom onset. Blood samples were taken on admission and at four time points within the first 24 h after PCI. Results In contrast to all other markers, copeptin levels were already elevated on admission and were higher with a shorter time from symptom onset to reperfusion and lower systolic blood pressure. Copeptin levels peaked immediately after symptom onset at a maximum of 249 pmol/L and normalized within 10 h. In contrast, CK-MB, cTnT, and hs-cTnT peaked after 14 h from symptom onset at a maximum of 275 U/L, 5.75 lg/L, and 4.16 lg/L, respectively, and decreased more gradually. Conclusions Copeptin has a distinct release pattern in patients with ST-elevation AMI, peaking within the first hour after symptom onset before conventional cardiac biomarkers and falling to normal ranges within the first day. Further studies are required to determine the exact role of copeptin in AMI suspects presenting within the first hours after symptom onset.

AB - Background Early detection of acute myocardial infarction (AMI) using cardiac biomarkers of myocardial necrosis remains limited since these biomarkers do not rise within the first hours from onset of AMI. We aimed to compare the temporal release pattern of the C-terminal portion of provasopressin (copeptin) with conventional cardiac biomarkers, including creatine kinase isoenzyme (CK-MB), cardiac troponin T (cTnT), and high-sensitivity cTnT (hs-cTnT), in patients with ST-elevation AMI. Methods We included 145 patients undergoing successful primary percutaneous coronary intervention (PCI) for a first ST-elevation AMI presenting within 12 h of symptom onset. Blood samples were taken on admission and at four time points within the first 24 h after PCI. Results In contrast to all other markers, copeptin levels were already elevated on admission and were higher with a shorter time from symptom onset to reperfusion and lower systolic blood pressure. Copeptin levels peaked immediately after symptom onset at a maximum of 249 pmol/L and normalized within 10 h. In contrast, CK-MB, cTnT, and hs-cTnT peaked after 14 h from symptom onset at a maximum of 275 U/L, 5.75 lg/L, and 4.16 lg/L, respectively, and decreased more gradually. Conclusions Copeptin has a distinct release pattern in patients with ST-elevation AMI, peaking within the first hour after symptom onset before conventional cardiac biomarkers and falling to normal ranges within the first day. Further studies are required to determine the exact role of copeptin in AMI suspects presenting within the first hours after symptom onset.

KW - Acute myocardial infarction

KW - Biomarkers

KW - Copeptin

KW - Temporal release pattern

KW - Troponin

UR - http://www.scopus.com/inward/record.url?scp=84856003210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856003210&partnerID=8YFLogxK

U2 - 10.1007/s00392-011-0343-y

DO - 10.1007/s00392-011-0343-y

M3 - Article

C2 - 21766239

AN - SCOPUS:84856003210

VL - 100

SP - 1069

EP - 1076

JO - Clinical Research in Cardiology

JF - Clinical Research in Cardiology

SN - 1861-0684

IS - 12

ER -